Navigation Links
Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
Date:11/7/2011

ertificates of deposit were $44.7 million, as compared to $54.3 million at September 30, 2010.

Conference Call and WebcastThe Company will host a conference call today, November 7, 2011 at 4:30 p.m. ET, to discuss its recent corporate developments and update its progress.  Eamonn Hobbs, President and Chief Executive Officer, will host the call.  To participate in the live call by telephone, please dial 800-322-5044 for domestic participants and 617-614-4927 for international participants, both using passcode 65515511.  Participants are asked to call the above numbers 5-10 minutes prior to the starting time.  To access the live webcast of the call, go to Delcath's website at www.delcath.com.

In addition, a taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 65413528. An archived webcast will also be available at www.delcath.com.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase 3 metastatic melanoma study, and the Company recently completed a multi-arm Phase 2 trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Delcath Hepatic CHEMOSAT® delivery system in April 2011. The Company has not yet received FDA approval for commerci
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
2. FDA Schedules Delcath Pre-New Drug Application Meeting Date
3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
4. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
5. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
8. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
9. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
10. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
11. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... Fla., Oct. 20, 2011 China Nuvo Solar Energy, ... Nevada has approved the Company,s requested corporate name change to ... and authorized the Board of Directors to change the Company,s ... of the Parent. As a result of the Nevada approval, ...
... FREMONT, Calif., Oct. 20, 2011 WaferGen Biosystems, ... announced organizational changes to strengthen domain leadership and ... of its SmartChip System.   As ... Lombardi, formerly President and a director of Helicos ...
Cached Medicine Technology:China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc. 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 3
(Date:5/20/2013)... York, NY (PRWEB) May 20, 2013 ... York City, today announced the introduction of its new ... powder that provides high density nutrition with plant extracts ... vegetables, herbs, spices, royal jelly, apple pectin, plant enzymes ... Hx™ offers the micronutrients and antioxidant levels of several ...
(Date:5/20/2013)... Hills, Utah (PRWEB) May 20, 2013 As a ... can be to effectively balance family, work, and a fit, healthy ... weight gain. , “It hit me like a ton of bricks ... Arnold. “I woke up one morning and realized I had lost ... time. I felt awful, I had little to no energy to ...
(Date:5/19/2013)... New York, NY (PRWEB) May 20, 2013 ... announce that they are representing a New York woman in ... running back with the National Football League (NFL). According ... Court, the Petitioner is seeking a declaration of paternity, order ... on behalf of her son with Mr. Walker. (Docket ...
(Date:5/19/2013)... Calif., May 20, 2013 Whole-cell pertussis vaccines ... acellular pertussis vaccines during a large recent outbreak, ... in Pediatrics . , Whole-cell pertussis vaccines, ... to 1990s, but were associated with safety concerns ... pertussis vaccines, which are also called DTaP. By ...
(Date:5/19/2013)... Alonso Krangle LLP a dedicated law ... lawsuit on behalf of a-24-year-old financial analyst rendered quadriplegic ... The diving accident lawsuit, which was filed in the Supreme ... Defendant held the property out as a bathing beach, but ... area. (Case No. 34556/12) , According to the diving accident ...
Breaking Medicine News(10 mins):Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:New Program Helps Busy Moms Become Healthier, Lose Weight, and Feel Great 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3Health News:Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak 2Health News:Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak 3Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3
... Ulagu”,Wondering what the above verses from Thirukurral written by ... special report about nanotechnology? // , ,“ Annuvai ... the ingenuity of its author, that he has compressed ... as if he had hollowed an atom, and enclosed ...
... proposes to change the curriculum for medicine by integrating ... within two years., ,"Today's medical curriculum is ... the modern and traditional practices in the new curriculum. ... time," said health minister, Ramadoss during National Seminar on ...
... men and occurs in men 65 years or older. It ... should undergo the routine examination of prostate and also test ... levels of PSA in blood. African-American men or men with ... screening exams at an earlier age. Signs and symptoms of ...
... that more and more women are now opting for ... new study in the September issue of the journal ... delivery become more varied and sophisticated, growing numbers of ... childbirth., ,Researchers from the University of Colorado had ...
... acne for more than six weeks were more than ... infection within one year as individuals with acne who ... study reports., ,Overuse of antibiotics has been held ... increase in increase in infectious illness. The present study ...
... is a genetic disorder characterized by distorted, sickle shaped red ... and organ damage to the kidneys, spleen, and liver. The ... the incidence is about 1 in 500., ,Despite much ... disease. Pain can be relieved, and the frequency and duration ...
Cached Medicine News:Health News:Scientists Consider About New Technology Called Nanotechnology 2Health News:Hydroxyurea Treatment For Children With Sickle Cell Disease 2
... table that performs as well as your ... use in major surgical suites where control ... B 810 brings better patient outcomes within ... articulation for maximum patient positioning and allows ...
Clearview Chlamydia is a rapid, easy-to-use test for the detection of Chlamydia trachomatis from female endocervical swab specimens....
10-mm (0.4-in) diameter cups have multi-color lead wires and 2-mm (0.08-in) holes for easy paste/collodion application. Available in a variety of lengths to suit many different needs....
... these head cap systems are packaged to ... Each Electro-Cap System features pure tin electrodes ... When you place your order, please specify ... head cap system and whether you want ...
Medicine Products: